Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805532 · ClinicalTrials.gov registry record · NA
Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans
A NA study of Depression and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
- 2
- Study locations
NCT00805532: Completed NA study of Depression and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.
NCT00805532 is a NA study of Depression and Post Traumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 81 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00805532, a NA study of Depression and Post Traumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
- 2
- Study locations
Study Summary
The present study is a randomized, controlled trial that compares Behavioral Activation (BA) to Treatment As Usual (TAU) in PTSD Specialty clinics, as early psychotherapeutic interventions for OIF/OEF veterans with posttraumatic stress disorder (PTSD).
Primary Outcome
The CAPS is a clinician-administered scale and is considered the "gold standard" for assessing the presence of PTSD. Items are ranked on Likert scales according to both frequency (0=never to 4=daily or almost every day) and intensity (0=none to 4=extreme) of symptoms, yielding an overall severity score by summing frequency and intensity ratings (range 0 to 136, with higher scores reflecting greater symptomatology). Scale scores corresponding to the 3 subcategories of PTSD symptoms (intrusive sym
Conditions Studied
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL Behavioral Activation treatment
Study Locations (2)
Oregon
- VA Medical Center, Portland - Portland
Washington
- VA Puget Sound Health Care System, Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT00805532 record still lists
NCT00805532 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT00805532 reports a single indexed study location in Oregon, Washington.
Frequently Asked Questions
What is clinical trial NCT00805532 about?
NCT00805532 is a clinical study titled "Behavioral Activation for PTSD/Depression Treatment in OIF/OEF Veterans". The present study is a randomized, controlled trial that compares Behavioral Activation (BA) to Treatment As Usual (TAU) in PTSD Specialty clinics, as early psychotherapeutic interventions for OIF/OEF veterans with posttraumatic stress disorder (PTSD).
What is the current status of trial NCT00805532?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2009-05. Estimated completion is 2013-07.
What conditions does trial NCT00805532 study?
This clinical trial studies the following conditions: Depression, Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT00805532?
The interventions under investigation include: Treatment as Usual (OTHER), Behavioral Activation treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00805532?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00805532 being conducted?
This trial has 2 study locations across Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00805532's enrollment target sits among peer trials
81 372nd of 679 higher than 308 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia